Institutional Biosafety Committee (IBC)

Unique in the nation, our affiliates send representation to an independent biosafety committee to review recombinant DNA/gene transfer research. Our core committee is composed of chairs and biosafety officers from academic centers. With this mechanism and without sacrificing scrupulous oversight safety, a trial involving recombinant DNA/gene transfer may be started much more expeditiously than in the past.

IBC Forms and Downloads

IBC Services provided by BRANY include: 

• Formation of IBC where needed
  • Core board of gene transfer and biosafety experts from academic centers
  • Network of non-affiliated community members
  • Biosafety officers for site inspection
  • Facilitation of all administrative requirements, including IBC registration and required reporting
• Expert review and consideration, including:
  • Safety Considerations
    • Risk Assessment
    • Containment levels
    • Assessment of the facilities, procedures, practices, and training an expertise of personnel involved
  • Appendix M
  • RAC Review (if applicable)
  • Surveillance, data reporting, and adverse event reporting requirements set forth in the NIH Guidelines
• Ongoing oversight by IBC (continuing review)
• Personalized and responsive service with assigned project coordinator, including:
  • Selection of appropriate IBC members
  • Registration of IBC with OBA/NIH
  • Review of IBC applications for completeness
  • Scheduling IBC meetings for initial and continuing review
  • Preparation of meeting agenda and distribution of materials for review
  • Correspondence between site, sponsor, IBC, and NIH
  • Maintenance of appropriate project records and minutes of IBC meetings
  • Scheduling site visits as needed
• Meetings scheduled on request
• Very competitive and transparent pricing (fees available upon request).